-Stephen H Petersdorf Researcher Activity Profile

Research Author Detailed Information 

Stephen H Petersdorf Publication Rate By Year

Stephen H Petersdorf has published 9 paper(s) in 2007, for a total of 9 research publications in total.

Stephen H Sh Petersdorf Author Information

LAST NAME: petersdorf

FIRST NAME: Stephen H

INITIALS: sh

AFFILIATION:

Papers

Stephen H Petersdorf's Publication Record

1. High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. Year Published: 2007
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98195, USA. agopal@u.washington.edu
2. The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation. Year Published: 2007
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
3. The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation. Year Published: 2007
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
4. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington.
5. The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. Year Published: 2007
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
6. The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation. Year Published: 2007
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
7. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu
8. The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. Year Published: 2007
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
9. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu